Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

Study ID: NCT06547866
Start Date: 2025-06-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

zanubrutinib + BGB-11417

Sponsor

French Innovative Leukemia Organisation

Source: clinicaltrials.gov

Share:
Add to list

Development of PRECISE: a Data Driven Personalized Suicide Prevention Intervention

Study ID: NCT06809348
Start Date: 2025-09-01
End Date: 2030-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

PRECISE

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

Cost-Effectiveness of ESWT Plus Rehabilitation vs Rehabilitation Alone in Post-Burn Scars

Study ID: NCT06913257
Start Date: 2025-04-22
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

104

Intervention / Treatment

ESWT Combined with Standard Rehabilitation

Standard Rehabilitation Therapy Alone

Sponsor

Al Hayah University in Cairo

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Platelet-rich Plasma in Management of Anosmia

Study ID: NCT06930248
Start Date: 2025-05-01
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Platelet rich plasma injection

Sponsor

Sohag University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Study ID: NCT06507748
Start Date: 2025-04-23
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

AlgometRx Nociometer

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Korea Post Marketing Surveillance (PMS) Study of Talzenna®

Study ID: NCT04982848
Start Date: 2025-12-31
End Date: 2026-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Talzenna

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer

Study ID: NCT06793748
Start Date: 2025-06
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

184

Intervention / Treatment

PEP-TISSEEL

TISSEEL Fibrin Sealant KIT

PEP-TISSEEL

TISSEEL Fibrin Sealant KIT

Sponsor

Rion Inc.

Source: clinicaltrials.gov

Share:
Add to list

WIN: a Feasibility Study of a Weight-Neutral Health Intervention

Study ID: NCT06922630
Start Date: 2025-05-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

56

Intervention / Treatment

WIN

Sponsor

Carsten dirksen

Source: clinicaltrials.gov

Share:
Add to list

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

Study ID: NCT05713630
Start Date: 2025-06-01
End Date: 2030-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

130

Intervention / Treatment

Tranexamic acid (TXA)

Placebo

Sponsor

Unity Health Toronto

Source: clinicaltrials.gov

Share:
Add to list

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

Study ID: NCT06918665
Start Date: 2025-08-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

52

Intervention / Treatment

ivermectin infant formula preparation

Standard ivermectin 3mg tablet

Sponsor

Murdoch Childrens Research Institute

Source: clinicaltrials.gov

Share:
Add to list